| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Debt-to-equity | 84.4 | % | +565% |
| Return On Equity | -1.04K | % | -463% |
| Return On Assets | -565 | % | -244% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 13.9M | shares | +5.4% |
| Common Stock, Shares, Outstanding | 13.8M | shares | +4.94% |
| Entity Public Float | 101M | USD | +78.5% |
| Common Stock, Value, Issued | 13.8K | USD | +4.95% |
| Weighted Average Number of Shares Outstanding, Basic | 13.6M | shares | +3.8% |
| Weighted Average Number of Shares Outstanding, Diluted | 13.6M | shares | +3.8% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 15.8M | USD | +73% |
| General and Administrative Expense | 3.8M | USD | +132% |
| Operating Income (Loss) | -19.6M | USD | -82% |
| Net Income (Loss) Attributable to Parent | -19.5M | USD | -85.6% |
| Earnings Per Share, Basic | -1 | USD/shares | -86.1% |
| Earnings Per Share, Diluted | -1 | USD/shares | -86.1% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 3.81M | USD | -34.6% |
| Assets | 3.81M | USD | -34.6% |
| Accounts Payable, Current | 1.05M | USD | |
| Employee-related Liabilities, Current | 207K | USD | +206% |
| Liabilities, Current | 1.62M | USD | +92.5% |
| Liabilities | 1.62M | USD | +92.5% |
| Retained Earnings (Accumulated Deficit) | -77.6M | USD | -33.5% |
| Stockholders' Equity Attributable to Parent | 2.18M | USD | -56.1% |
| Liabilities and Equity | 3.81M | USD | -34.6% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -1.83M | USD | -2.91% |
| Net Cash Provided by (Used in) Financing Activities | 492K | USD | +64.6% |
| Common Stock, Shares Authorized | 100M | shares | 0% |
| Common Stock, Shares, Issued | 13.8M | shares | +4.94% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -1.34M | USD | +9.53% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 3.81M | USD | -34.6% |
| Deferred Tax Assets, Valuation Allowance | 6.3M | USD | +39.8% |
| Deferred Tax Assets, Operating Loss Carryforwards | 6.3M | USD | +39.8% |
| Share-based Payment Arrangement, Expense | 4.22M | USD | +129% |